MVAC-therapy for advanced urothelial carcinoma in an anuric renal transplant recipient.
Matzkies
F K
FK
Medizinische Poliklinik, Radiologische Abteilung and Medizinische Klinik A: Hämatologie- Onkologie, Westfälische Wilhemsuniversität Münster, Germany. matzkies@uni-muenster.de
Tombach
B
B
Dietrich
M
M
Kisters
K
K
Barenbrock
M
M
Schaefer
R M
RM
Berdel
W E
WE
Rahn
K H
KH
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000493:pharmacokinetics; D001002:Anuria / Q000503:physiopathology; D002945:Cisplatin / Q000008:administration & dosage / Q000493:pharmacokinetics; D004317:Doxorubicin / Q000008:administration & dosage / Q000493:pharmacokinetics; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000502:physiology; D008207:Lymphatic Metastasis; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000493:pharmacokinetics; D012008:Recurrence; D001749:Urinary Bladder Neoplasms / Q000150:complications* / Q000188:drug therapy*; D014747:Vinblastine / Q000008:administration & dosage / Q000493:pharmacokinetics
D014747:Vinblastine; D004317:Doxorubicin; D002945:Cisplatin; D008727:Methotrexate